Michelle Mitchell, chief executive of Cancer Research UK
Flashback to February 4th, the start of Cancer Research UK’s 20th anniversary year. The then Secretary of State for Health and Social Care, Sajid Javid, declared a ‘War on Cancer’, committing to publish a 10-year plan, which promised to focus on research and innovation, boost the cancer workforce and tackle inequalities. Nine months and two governments later and we have no sign of strategy, plan or funding. Neither Steve Barclay nor Rishi Sunak have uttered a word about it.
Improving cancer survival is central to our mission. The good news is, over the last 40 years, cancer survival has doubled. This is cause for celebration, but don’t get the bunting out yet. Over recent years, improvements in early diagnosis and cancer survival have been happening far too slowly. The NHS Long Term Plan aims to diagnose 75% of cancers early by 2028, but Cancer Research UK predicts that, to reach this, around 100,000 extra patients will need to be diagnosed early (stage 1 or 2) each year in England.
Earlier this month, Jeremy Hunt, the Chancellor, who knows a thing or two about health policy, called for public services with “Scandinavian quality [and] Singaporean efficiency”. A nice thought, though today, cancer outcomes in the UK lag behind comparable countries, both in Scandinavia and around the world. All of this begs the question: is improving cancer survival still a priority for this Conservative Government?
It’s no secret that the NHS is under immense pressure. Cancer waiting time targets are repeatedly missed each month and the recent National Audit Office report has shown that plans to bring these waits down by 2025 are at serious risk. NHSE’s target of ensuring 85% of patients start treatment within 62 days of an urgent referral for suspected cancer was missed again in September 2022 and hasn’t been met since 2015. I hear stories from the nurses who operate our helpline at Cancer Research UK, of callers who are distressed and anxious about long waits to see their doctor to investigate symptoms. Cancer is a progressive disease. Just a few weeks can make a real difference to treatment options and how effective they are for some patients.
Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding. Additional funds for the NHS in England were announced in the Autumn Statement. They make a difference. But the health service needs to transform if it is to respond to increasing numbers of people getting cancer.
Preventing cancer in the first place must be a priority. The Javed Khan Review, commissioned by the UK Government, powerfully outlines how to make smoking obsolete. Steve Barclay needs to accept the recommendations and outline when and how they will be implemented. Together with bold action on obesity, this would help us all live healthier lives, and reduce our cancer risk.
Improving early diagnosis is integral to improving cancer survival. When diagnosed at the earliest stage at least 9 in 10 will survive bowel cancer for five years or more, compared with only 1 in 10 when diagnosed at the latest stage. We need to diagnose cancers earlier by getting patients tested faster and reducing the time it takes to get results back. Optimising cancer screening services would help to spot cancers earlier when treatment is more effective and ensuring that the NHS can deliver the most innovative clinical trials would improve patient access to novel medicines.
Some government initiatives have been promising. Community Diagnostic Centres offer quicker access to diagnostic tests, and it’s now easier for GPs to refer directly for these tests. But continued investment in kit is essential and underpinning all of this is the need for a long-term costed plan for workforce. 1 in 10 NHS posts are currently vacant.
Committing to an ambitious 10-year cancer strategy, plan and funding which improves cancer survival could be a great legacy for the Government. It makes financial sense to ensure our NHS is fit for the challenges of the future. It makes moral sense to give people affected by cancer the support they deserve. And it makes political sense for the Conservative Government to deliver on their promises ahead of the next general election. If they don’t act, maybe the Labour Party will?
Michelle Mitchell is the chief executive officer of Cancer Research UK
This article was originally published in the New Statesman.
Patrick McGuire December 22, 2022
This is an excellent Opinion piece. We need CRUK to do much more campaigning along these lines as much of the UK public remains unaware of the relatively poor state of the UK’s cancer provision and outcomes.